Cargando…

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles

Targeted therapy of cancer using oncolytic viruses has generated much interest over the past few years in the light of the limited efficacy and side effects of standard cancer therapeutics for advanced disease. In 2006, the world witnessed the first government-approved oncolytic virus for the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Han Hsi, Lemoine, Nicholas R., Wang, Yaohe
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883714/ https://www.ncbi.nlm.nih.gov/pubmed/20543907 http://dx.doi.org/10.3390/v2010078

Ejemplares similares

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
por: Ferguson, Mark S., et al.
Publicado: (2012)

Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
por: Howells, Anwen, et al.
Publicado: (2017)

Update on oncolytic viral therapy – targeting angiogenesis
por: Tysome, James R, et al.
Publicado: (2013)

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
por: Yuan, Ming, et al.
Publicado: (2016)

Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
por: Marelli, Giulia, et al.
Publicado: (2018)

Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022)

Overcoming Obstacles
por: Braile, Domingo M.
Publicado: (2015)

Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
por: Petty, Amy J., et al.
Publicado: (2020)

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2022)

An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
por: Sun, Yijie, et al.
Publicado: (2022)

Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer
por: Ali, Osman, et al.
Publicado: (2021)

Immune checkpoint inhibitors in cancer therapy
por: Webb, Eika S., et al.
Publicado: (2018)

Overcoming the limitations of locally administered oncolytic virotherapy
por: Hong, JinWoo, et al.
Publicado: (2019)

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
por: Lee, Donghyun, et al.
Publicado: (2021)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Trial watch: Oncolytic viruses for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch:: Oncolytic viruses for cancer therapy
por: Pol, Jonathan, et al.
Publicado: (2014)

Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
por: Ferguson, Mark S., et al.
Publicado: (2020)

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
por: Yang, Fan, et al.
Publicado: (2023)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

Advances in biomaterials for skeletal muscle engineering and obstacles still to overcome
por: Smoak, M.M., et al.
Publicado: (2020)

Oncolytic viruses in cancer therapy
por: Vähä-Koskela, Markus J.V., et al.
Publicado: (2007)

Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Lu, Yuanfei, et al.
Publicado: (2022)

Oncolytic virus therapy in cancer: A current review
por: Santos Apolonio, Jonathan, et al.
Publicado: (2021)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)

Sperm DNA fragmentation: overcoming standardization obstacles
por: Majzoub, Ahmad, et al.
Publicado: (2017)

Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus
por: Kirn, David H, et al.
Publicado: (2007)

Developing Oncolytic Viruses for the Treatment of Cervical Cancer
por: Kalafati, Eleni, et al.
Publicado: (2023)

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
por: Kim, Youra, et al.
Publicado: (2015)

A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
por: Ahmed, Jahangir, et al.
Publicado: (2020)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Pierce, Kyle M., et al.
Publicado: (2021)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020)

An obstacle to overcome: cerebral toxoplasmosis in patients living with HIV
por: Filipescu, Irina, et al.
Publicado: (2014)

Dietary Patterns, Genes, and Health: Challenges and Obstacles to be Overcome
por: Frazier-Wood, Alexis C.
Publicado: (2014)

Recruitment, Enrollment, and Retention: Creative Techniques to Overcome Obstacles
por: Sefcik, Justine, et al.
Publicado: (2021)

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
por: Marchini, Antonio, et al.
Publicado: (2016)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v2l2vsspci468m386qu0crnfaf